Andere Sprachen Monopar Therapeutics Inc.

Aktien

A2PQNF

US61023L1089

MNPR

Realtime-Estimate Cboe BZX Andere Börsenplätze 20:45:49 09.05.2024			% 5 Tage	% 1. Jan.
0.736 ^USD	-1.87%		+10.59%	+114.55%

16.04.	Monopar Therapeutics Inc. gibt die Einreichung eines Patents zum Schutz der MNPR-101 Radiopharma-Optimierungsergebnisse bekannt	CI
11.04.	MONOPAR THERAPEUTICS INC. : JonesTrading Institutional Services gibt eine Kauf-Bewertung ab	ZM

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Monopar Therapeutics Reports First Quarter 2024 Financial Results and Strategic Focus on its Radiopharma Pipeline	13:00
Monopar Announces Radiopharma Presentation Selected for Society of Nuclear Medicine and Molecular Imaging 2024 Annual Meeting	18.04.
Monopar Announces Radiopharma Presentation Selected for Society of Nuclear Medicine and Molecular Imaging 2024 Annual Meeting	18.04.
Monopar Therapeutics Files Provisional Patent for New MNPR-101 Construct	16.04.
Monopar Announces Filing of Patent Protecting MNPR-101 Radiopharma Optimization Findings	16.04.
Monopar Therapeutics Inc. Announces Filing of Patent Protecting MNPR-101 Radiopharma Optimization Findings	16.04.
North American Morning Briefing : Big Banks Kick -2-	12.04.
Monopar Initiates Radiopharma Phase 1 Clinical Trial for MNPR-101-Zr in Advanced Cancer Patients	10.04.
Monopar Therapeutics Inc Initiates Radiopharma Phase 1 Clinical Trial for MNPR-101-Zr in Advanced Cancer Patients	10.04.
Monopar Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Developments	28.03.
Monopar Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28.03.
Monopar Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Developments	28.03.
Monopar Announces Positive Preclinical Therapeutic Isotope Data for its MNPR-101 Radiopharma Program	05.03.
Monopar Therapeutics Inc. Announces Positive Preclinical Therapeutic Isotope Data for its MNPR-101 Radiopharma Program	05.03.
Monopar Provides Update on MNPR-101-Zr Radiopharma Clinical Trial	27.02.
Sector Update: Health Care Stocks Gain Late Afternoon	22.02.
Sector Update: Health Care	22.02.
Monopar Therapeutics Shares Rise on 'Promising' Preclinical Cancer Treatment Trial Results	22.02.
Top Midday Gainers	22.02.
Monopar Announces Promising Preclinical Data for its MNPR-101 Radiopharma Program Targeting Advanced Cancers	22.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Monopar Therapeutics Inc.

Aktien

A2PQNF

US61023L1089

MNPR

Andere Sprachen

Filter